Seminoma Clinical Stage 1-Patterns of Care in Germany

被引：16

作者：

Dieckmann, Klaus-Peter ^{[1
]}

Dralle-Filiz, Inken ^{[1
]}

Heinzelbecker, Julia ^{[4
]}

Matthies, Cord ^{[2
]}

Bedke, Jens ^{[5
]}

Ellinger, Joerg ^{[7
]}

Sommer, Joerg ^{[8
]}

Haben, Bjoern ^{[9
]}

Souchon, Rainer ^{[6
]}

Anheuser, Petra ^{[1
]}

Pichlmeier, Uwe ^{[3
]}

机构：

[1] Albertinen Krankenhaus, Urol Klin, Suentelstr 11a, DE-22457 Hamburg, Germany

[2] Bundeswehr Krankenhaus Hamburg, Urol Abt, Hamburg, Germany

[3] Univ Klinikum Eppendorf, Inst Med Stat & Epidemiol, Hamburg, Germany

[4] Univ Klinikum Mannheim, Urol Klin, Mannheim, Germany

[5] Univ Klinikum Tuebingen, Urol Klin, Tubingen, Germany

[6] Univ Klinikum Tuebingen, Klin Radioonkol, Tubingen, Germany

[7] Univ Klinikum Bonn, Urol Klin, Bonn, Germany

[8] St Franziskus Hosp Lohne, Urol Klin, Lohne, Germany

[9] St Marien Krankenhaus Ahaus, Urol Abt, Ahaus, Germany

来源：

UROLOGIA INTERNATIONALIS | 2016年 / 96卷 / 04期

关键词：

Testicular germ cell neoplasms; Seminoma; Patterns of care; Carboplatin; Surveillance; Radiotherapy; I TESTICULAR SEMINOMA; EUROPEAN CONSENSUS CONFERENCE; PRACTICE GUIDELINES; ADJUVANT TREATMENT; CELL-CANCER; SURVEILLANCE; MANAGEMENT; RADIOTHERAPY; TESTIS; DIAGNOSIS;

D O I：

10.1159/000443214

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: International guidelines are ambivalent regarding the recommendations for the management of clinical stage 1 (CS1) seminoma. Patients and Methods: During 2008-2013, 1,050 patients with seminoma CS1 were prospectively registered with regard to assessing management modality (radiotherapy, carboplatin, surveillance). Associations with tumor size, rete testis invasion, age, year of diagnosis, type of institution, and geographic location were assessed. Results: Of the total number of patients, 49.3% received carboplatin 1 course, 8.5% carboplatin 2 courses, 35.9% surveillance, and 6.3% radiotherapy. In 2013, surveillance increased significantly to 57.9%. Treatment decisions were significantly associated with rete testis invasion and tumor size. Carboplatin was applied significantly more in office clinics than elsewhere. There is some regional variation regarding treatment preferences. Conclusions: The rising acceptance of surveillance mirrors international trends. The associations with prognostic factors demonstrate care givers to be compliant with contemporary guidelines. The association with the type of institution suggests non-oncological factors to be also relevant in decision making. (C) 2016 S. Karger AG, Basel

引用

页码：390 / 398

页数：9

共 42 条

[1] EAU Guidelines on Testicular Cancer: 2011 Update [J].

Albers, Peter ;

Albrecht, Walter ;

Algaba, Ferran ;

Bokemeyer, Carsten ;

Cohn-Cedermark, Gabriella ;

Fizazi, Karim ;

Horwich, Alan ;

Laguna, Maria Pilar .

EUROPEAN UROLOGY, 2011, 60 (02) :304-319

[2]

Bagnell Scott, 2004, Can J Urol, V11, P2194

[3] Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer [J].

Beyer, J. ;

Albers, P. ;

Altena, R. ;

Aparicio, J. ;

Bokemeyer, C. ;

Busch, J. ;

Cathomas, R. ;

Cavallin-Stahl, E. ;

Clarke, N. W. ;

Classen, J. ;

Cohn-Cedermark, G. ;

Dahl, A. A. ;

Daugaard, G. ;

De Giorgi, U. ;

De Santis, M. ;

De Wit, M. ;

De Wit, R. ;

Dieckmann, K. P. ;

Fenner, M. ;

Fizazi, K. ;

Flechon, A. ;

Fossa, S. D. ;

Germa Lluch, J. R. ;

Gietema, J. A. ;

Gillessen, S. ;

Giwercman, A. ;

Hartmann, J. T. ;

Heidenreich, A. ;

Hentrich, M. ;

Honecker, F. ;

Horwich, A. ;

Huddart, R. A. ;

Kliesch, S. ;

Kollmannsberger, C. ;

Krege, S. ;

Laguna, M. P. ;

Looijenga, L. H. J. ;

Lorch, A. ;

Lotz, J. P. ;

Mayer, F. ;

Necchi, A. ;

Nicolai, N. ;

Nuver, J. ;

Oechsle, K. ;

Oldenburg, J. ;

Oosterhuis, J. W. ;

Powles, T. ;

Rajpert-De Meyts, E. ;

Rick, O. ;

Rosti, G. .

ANNALS OF ONCOLOGY, 2013, 24 (04) :878-888

[4] Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology [J].

Bilici, Ahmet ;

Ozturk, Turkan ;

Turkmen, Esma ;

Odabas, Hatice ;

Cihan, Sener ;

Selcukbiricik, Fatih ;

Erdogan, Bulent ;

Urakci, Zurat ;

Kandemir, Nurten ;

Bayoglu, Ibrahim Vedat ;

Demirci, Umut ;

Duran, Ayse Ocak ;

Sendur, Mehmet Ali Nahit ;

Yavuzer, Dilek ;

Harputluoglu, Hakan ;

Kavgaci, Halil ;

Gumus, Mahmut .

WORLD JOURNAL OF UROLOGY, 2015, 33 (10) :1613-1622

[5] UK Management Practices in Stage I Seminoma and the Medical Research Council Trial of Imaging and Schedule in Seminoma Testis Managed with Surveillance [J].

Cafferty, F. H. ;

Gabe, R. ;

Huddart, R. A. ;

Rustin, G. ;

Williams, M. P. ;

Stenning, S. P. ;

Bara, A. ;

Bathia, R. ;

Freeman, S. C. ;

Alder, L. ;

Joffe, J. K. .

CLINICAL ONCOLOGY, 2012, 24 (01) :25-29

[6] Treatment of early stage testicular seminoma [J].

Classen, J ;

Souchon, R ;

Hehr, T ;

Bamberg, M .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (08) :475-481

[7] Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG) [J].

Classen, J ;

Schmidberger, H ;

Meisner, C ;

Winkler, C ;

Dunst, J ;

Souchon, R ;

Weissbach, L ;

Budach, V ;

Alberti, W ;

Bamberg, M .

BRITISH JOURNAL OF CANCER, 2004, 90 (12) :2305-2311

[8]

De Giorgi U, 2008, TUMORI, V94, P96

[9]

Dieckmann KP, 2009, UROLOGE, V48, P419, DOI 10.1007/s00120-009-1936-1

[10] Adjuvant treatment of clinical stage I seminoma:: Is a single course of carboplatin sufficient? [J].

Dieckmann, KP ;

Brüggeboes, B ;

Pichlmeier, U ;

Küster, J ;

Müllerleile, U ;

Bartels, H .

UROLOGY, 2000, 55 (01) :102-106

← 1 2 3 4 5 →